Flow cytometry analysis showed that more than 90% of cells from spleen, lymph node, and BM of the lymphoma cell transplants exhibited aberrant B220+ IgM− cell populations (Figure 6C), which were comparable with the populations in the donor lymphoma (Figure 5A, middle panel). This evidence concerns the gene CD40LG and lymphoma.